cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc2bj79f
title: CCDC 2160554: Experimental Crystal Structure Determination

description: Related Article: Sushree Ranjan Sahoo, Biswajit Das, Debayan Sarkar, Hans Reuter|2022|J.Org.Chem.|87|13529|doi:10.1021/acs.joc.2c00994
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2bknq9
title: CCDC 2161931: Experimental Crystal Structure Determination

description: Related Article: Sushree Ranjan Sahoo, Biswajit Das, Debayan Sarkar, Hans Reuter|2022|J.Org.Chem.|87|13529|doi:10.1021/acs.joc.2c00994
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cmkwg
title: CCDC 2193556: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cmkxh
title: CCDC 2193557: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cmkyj
title: CCDC 2193558: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5519/qd.o90746ej
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (27 records)
DOI: 10.5517/ccdc.csd.cc2cmkzk
title: CCDC 2193559: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml0m
title: CCDC 2193560: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml1n
title: CCDC 2193561: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml2p
title: CCDC 2193562: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml3q
title: CCDC 2193563: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml4r
title: CCDC 2193564: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml5s
title: CCDC 2193565: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml6t
title: CCDC 2193566: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cml7v
title: CCDC 2193567: Experimental Crystal Structure Determination

description: Related Article: Georgios Spiridopoulos, Martin Bonath, Cäcilia Maichle-Mössmer, Reiner Anwander|2022|Organometallics|41|2854|doi:10.1021/acs.organomet.2c00391
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2cnpxn
title: CCDC 2194642: Experimental Crystal Structure Determination

description: Related Article: Jun Yao, Dandan Hu, Jun-Qi Zhang, Yili Zhang, Xinyi Ma, Jiang Liu, Jiali Wang, Bukuo Ni, Hongjun Ren|2022|J.Org.Chem.|87|14685|doi:10.1021/acs.joc.2c02004
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.57745/jeq9fb
title: Sequences 16S (2020_09_22 06_23_07 UTC).tar

description: :unav
DOI: 10.25934/pr00000248.0
title: Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study to Determine the Efficacy and Safety of Retigabine (1200 mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures'

description: This Phase 3 study is being conducted to evaluate the efficacy and safety of retigabine dosed at 1200 mg/day, in three equally divided doses, compared with placebo in patients with epilepsy who are receiving up to three established antiepileptic drugs (AEDs).
DOI: 10.6084/m9.figshare.21510177
title: Clinico-epidemiological profile and predictors of outcome among Guillain Barre Syndrome patients in Mangalore, India

description: The SPSS spreadsheet contains the research data.
DOI: 10.6084/m9.figshare.21510177.v1
title: Clinico-epidemiological profile and predictors of outcome among Guillain Barre Syndrome patients in Mangalore, India

description: The SPSS spreadsheet contains the research data.
DOI: 10.5281/zenodo.7298531
title: Data for article "Assembling diuranium complexes in different states of charge with a bridging redox-active ligand"

description: This upload contains raw data (NMR, X-Ray, Elemental Analysis, AC & DC SQUID, EPR) files for the article.
DOI: 10.5281/zenodo.7298530
title: Data for article "Assembling diuranium complexes in different states of charge with a bridging redox-active ligand"

description: This upload contains raw data (NMR, X-Ray, Elemental Analysis, AC & DC SQUID, EPR) files for the article.
DOI: 10.25934/pr00005918.0
title: Available IPD datapackage for study 'A Multicenter, Open-label, Long-term, Safety, Tolerability and Efficacy Study of Retigabine in Adult Epilepsy Patients With Partial-onset Seizures (Extension of Study VRX-RET-E22-301)'

description: The purpose of this study is to evaluate the safety and tolerability of long-term therapy with retigabine administered as adjunctive therapy in adult epilepsy patients with partial-onset seizures, who completed the VRX-RET-E22-301 double-blind study. The efficacy of long-term treatment with retigabine and patient quality of life will also be assessed.
DOI: 10.18112/openneuro.ds003126.v1.3.0
title: Reading-related functional activity in children with isolated spelling deficits and dyslexia
DOI: 10.5281/zenodo.6344749
title: Multi-label Datasets used in "Adapting Transformers for Multi-Label Text Classification"

description: The three Multi-Label datasets used in the article "Adapting Transformers for Multi-Label Text Classification". - AAPD Dataset (ArXiv Academic Paper Dataset) [Yang et al. 2018]<sup>1</sup> - Reuters-21578 Dataset: https://archive.ics.uci.edu/ml/datasets/reuters-21578+text+categorization+collection - MFHAD (Multilabel French HAL Abstracts Dataset) <sup>1</sup>Pengcheng Yang, Xu Sun, Wei Li, Shuming Ma, Wei Wu, and Houfeng Wang. 2018.<br> SGM: Sequence Generation Model for Multi-label Classification. In Proceedings<br> of the 27th International Conference on Computational Linguistics. Association for<br> Computational Linguistics, Santa Fe, New Mexico, USA, 3915–3926.
DOI: 10.5281/zenodo.6344750
title: Multi-label Datasets used in "Adapting Transformers for Multi-Label Text Classification"

description: The three Multi-Label datasets used in the article "Adapting Transformers for Multi-Label Text Classification". - AAPD Dataset (ArXiv Academic Paper Dataset) [Yang et al. 2018]<sup>1</sup> - Reuters-21578 Dataset: https://archive.ics.uci.edu/ml/datasets/reuters-21578+text+categorization+collection - MFHAD (Multilabel French HAL Abstracts Dataset) <sup>1</sup>Pengcheng Yang, Xu Sun, Wei Li, Shuming Ma, Wei Wu, and Houfeng Wang. 2018.<br> SGM: Sequence Generation Model for Multi-label Classification. In Proceedings<br> of the 27th International Conference on Computational Linguistics. Association for<br> Computational Linguistics, Santa Fe, New Mexico, USA, 3915–3926.
DOI: 10.5281/zenodo.7298581
title: Multi-label Datasets used in "Adapting Transformers for Multi-Label Text Classification"

description: The three Multi-Label datasets used in the article "Adapting Transformers for Multi-Label Text Classification". - AAPD Dataset (ArXiv Academic Paper Dataset) [Yang et al. 2018]<sup>1</sup> - Reuters-21578 Dataset: https://archive.ics.uci.edu/ml/datasets/reuters-21578+text+categorization+collection - MFHAD (Multilabel French HAL Abstracts Dataset) <sup>1</sup>Pengcheng Yang, Xu Sun, Wei Li, Shuming Ma, Wei Wu, and Houfeng Wang. 2018.<br> SGM: Sequence Generation Model for Multi-label Classification. In Proceedings<br> of the 27th International Conference on Computational Linguistics. Association for<br> Computational Linguistics, Santa Fe, New Mexico, USA, 3915–3926.
DOI: 10.6084/m9.figshare.21270690.v1
title: Supplementary Material for: IRF4 gene expression on the trail of molecular response: looking at chronic myeloid leukemia from another perspective

description: Introduction Interferon regulatory factor 4 (IRF4) is a transcriptional factor with a key role in the modulation of inflammation and immune surveillance. The IRF4 gene is downregulated in Philadelphia-negative myeloproliferative neoplasms, and its expression is associated with prognosis and response to treatment. Methods We evaluated the IRF4 expression kinetics during tyrosine kinase inhibitor (TKI) treatment in a cohort of 116 chronic myeloid leukemia (CML) patients to elucidate its role in the disease course. Results A relationship between the IRF4 expression and the disease burden was observed at various disease stages. A correlation analysis between the International Scale (IS) and IRF4 values confirmed this close association. A significant increase is detected after 3 months of TKI treatment. Patients achieving early molecular response (EMR) had higher IRF4 values at both diagnosis and after 3 months of therapy as compared to those failing the EMR target. Patients achieving treatment-free remission (TFR) did not show IRF4 fluctuations during monitoring, while a decreased IRF4 expression emerged at the time of molecular relapse. Conclusion Our data seem to confirm the relevance of IRF4 in the pathogenesis of CML, suggesting a pivotal role at the disease onset and a predictive value during the CML course.
DOI: 10.6084/m9.figshare.21270690
title: Supplementary Material for: IRF4 gene expression on the trail of molecular response: looking at chronic myeloid leukemia from another perspective

description: Introduction Interferon regulatory factor 4 (IRF4) is a transcriptional factor with a key role in the modulation of inflammation and immune surveillance. The IRF4 gene is downregulated in Philadelphia-negative myeloproliferative neoplasms, and its expression is associated with prognosis and response to treatment. Methods We evaluated the IRF4 expression kinetics during tyrosine kinase inhibitor (TKI) treatment in a cohort of 116 chronic myeloid leukemia (CML) patients to elucidate its role in the disease course. Results A relationship between the IRF4 expression and the disease burden was observed at various disease stages. A correlation analysis between the International Scale (IS) and IRF4 values confirmed this close association. A significant increase is detected after 3 months of TKI treatment. Patients achieving early molecular response (EMR) had higher IRF4 values at both diagnosis and after 3 months of therapy as compared to those failing the EMR target. Patients achieving treatment-free remission (TFR) did not show IRF4 fluctuations during monitoring, while a decreased IRF4 expression emerged at the time of molecular relapse. Conclusion Our data seem to confirm the relevance of IRF4 in the pathogenesis of CML, suggesting a pivotal role at the disease onset and a predictive value during the CML course.
DOI: 10.6084/m9.figshare.21509889.v1
title: Supplementary Material for: Dietary Protein and Fiber Affect Gut Microbiome and Treg/Th17 Commitment in Chronic Kidney Disease Mice

description: <b><i>Background:</i></b> Patients with chronic kidney disease (CKD) have dysbiosis, dysmetabolism, and immune dysregulation. Gut microbiome plays an important role shaping the immune system which is an important modulator of CKD progression. <b><i>Methods:</i></b> We compared the effect of a diet low in protein and high in fiber (LP-HF; <i>n</i> = 7) to that of diet rich in protein, but low in fiber (HP-LF; <i>n</i> = 7) on gut microbiome and T-cell commitment in male CKD (Alb/TGF-β1) mice. The gut microbiomes of these mice were subjected to 16S rRNA taxonomic profiling at baseline, 6 weeks and 12 weeks of the study. <b><i>Results:</i></b> The LP-HF diet was associated with an increase in <i>Butyricicoccus pullicaecorum</i> BT, a taxon whose functions include those closely related to butyric acid synthesis (Kendall’s W statistic = 180 in analysis of microbiome composition). HP-LF diet was associated with increased abundance of two predominantly proteolytic bacterial strains related to <i>Parabacteroides distasonis</i> (W statistic = 173), <i>Mucispirillum schaedleri</i>, and <i>Bacteroides dorei</i> (W statistic = 192). Pathway analysis suggested that the LP-HF diet induced carbohydrate, lipid, and butyrate metabolism. As compared with HP-LF mice, LP-HF mice had 1.7-fold increase in CD4+Foxp3+Treg cells in spleen and 2.4-fold increase of these cells in peripheral blood. There was an 87% decrease in percentage of CD4+ Th17 + cells in spleen and an 85% decrease in peripheral blood, respectively, in LP-HF mice compared to the HP-LF mice. <b><i>Conclusion:</i></b> The LP-HF diet promotes the proliferation of saccharolytic bacteria and favors T-cell commitment toward Treg cells in a CKD mouse of model. Clinical significance of the finding needs to be further investigated.
DOI: 10.6084/m9.figshare.20625480
title: Supplementary Material for: Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study

description: Background: A probiotic mixture prevented epithelial barrier impairment in various experimental models. The objective was to evaluate its effects in patients suffering from IBS-D with confirmed leaky gut. Methods: IBS D patients with increased intestinal permeability measured by radionuclide tracers were enrolled in this pilot, open-label, prospective, interventional, single-center, Phase IV study. Patients received two capsules of a multistrain probiotic a day for 30 days and were evaluated by repeated intestinal permeability test, the Bristol Stool Scale, and patient-perceived quality of life and satisfaction. Results: Of the 30 enrolled patients (mean age: 42.1 [SD: 13.1] years; female: 60%), 27 completed the study (Full Analysis Set [FAS]), 18 had no major protocol violation (Per Protocol Set [PPS]). On D30, an improvement of intestinal permeability was observed in 81.5% of patients in FAS, normalization being observed in 37% of the participants (44% in PPS). Mean intestinal permeability was significantly decreased: baseline minus D30, 3.4 (95%CI: 1.7, 5.2); IBS-QOL Total score was significantly increased: D30 minus baseline, 8.0 (95%CI: 3.0, 12.9); stool consistency was significantly improved. On D15 and D30, 96.3% of patients claimed that their IBS symptoms had been satisfactory alleviated, and a significant improvement was reported for the following VAS-IBS items: Abdominal pain, Diarrhea, Impact of gastrointestinal problems in daily life. Compliance and tolerance were satisfactory. Conclusion: The multistrain probiotic tested may reduce intestinal permeability in a considerable proportion of patients and may improve abdominal pain, stool consistency, and quality of life. These results pave the way for larger, placebo-controlled clinical studies.
DOI: 10.6084/m9.figshare.20971855.v1
title: Supplementary Material for: Drug Exposure and Risk of Microscopic Colitis: A Systematic Review and Meta-analysis

description: Background and objectives: Microscopic Colitis (MC) is a chronic inflammatory bowel disease, characterized by watery diarrhoea, normal radiological and endoscopic appearance. Concern regarding a potential association between drug exposure and MC has recently emerged. We sought to systematically review and summarize the evidence for the potential association. Methods: A systematic review and meta-analysis were performed to evaluate the incidence of MC associated with exposure to drug. The PubMed and Embase databases were searched to identify potential studies for inclusion. Results: Twelve case-control studies were included in the meta-analysis. The results showed exposure to NSAID (OR, 1.64; 95% CI 1.14-2.37; P&lt;0.001), PPI (OR, 2.36; 95% CI 1.59-3.52; P&lt;0.001), SSRI (OR, 2.16; 95% CI 1.5-3.13; P&lt;0.001), or aspirin (OR, 2.84; 95% CI 1.4–5.76; P &lt; 0.001) was related to the incidence of MC; however, such relationships in PPI and SSRI may be modulated by the selection of controls. Furthermore, we did not found a positive association with other drug exposure and MC. Conclusion: This meta-analysis indicated that NSAID, PPI, SSRI, or aspirin consumption may increase the risk for MC. Further studies exploring drug-induced microscopic colitis should include control groups with diarrhea, and not only healthy controls.
DOI: 10.5281/zenodo.4957490
title: Data for "Capturing variation in metagenomic assembly graphs with MetaCortex".

description: Data for paper "Capturing variation in metagenomic assembly graphs with MetaCortex". Includes all assemblies, simulated reads, and simulated genomes.
DOI: 10.5281/zenodo.4957491
title: Data for "Capturing variation in metagenomic assembly graphs with MetaCortex".

description: Data for paper "Capturing variation in metagenomic assembly graphs with MetaCortex". Includes all assemblies, simulated reads, and simulated genomes.
DOI: 10.5281/zenodo.6616437
title: Data for "Capturing variation in metagenomic assembly graphs with MetaCortex".

description: Data for paper "Capturing variation in metagenomic assembly graphs with MetaCortex". Includes all assemblies, simulated reads, and simulated genomes.
DOI: 10.5281/zenodo.7298574
title: Data for "Capturing variation in metagenomic assembly graphs with MetaCortex".

description: Data for paper "Capturing variation in metagenomic assembly graphs with MetaCortex". Includes all assemblies, simulated reads, and simulated genomes.